Víctor Manuel
Becerra Muñoz
Publicaciones en las que colabora con Víctor Manuel Becerra Muñoz (20)
2025
-
Impact of mechanical circulatory support on outcomes in Takotsubo syndrome complicated by cardiogenic shock: Insights from the RETAKO registry
International Journal of Cardiology, Vol. 419
2024
-
Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)
Journal of Clinical Medicine, Vol. 13, Núm. 9
-
Risk prediction of major cardiac adverse events and all-cause death following covid-19 hospitalization at one year follow-up: The HOPE-2 score
European Journal of Internal Medicine, Vol. 124, pp. 108-114
2023
-
Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19
Journal of Clinical Medicine, Vol. 12, Núm. 11
-
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)
Journal of Clinical Medicine, Vol. 12, Núm. 2
-
Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry
Frontiers in Endocrinology, Vol. 14
-
Spontaneous coronary artery dissection and ST-segment elevation myocardial infarction: Does clinical presentation matter?
International Journal of Cardiology, Vol. 373, pp. 1-6
2021
-
Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation
International Journal of Cardiology, Vol. 345, pp. 29-35
-
Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19
European Journal of Clinical Investigation, Vol. 51, Núm. 1
-
Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry
Obesity Research and Clinical Practice, Vol. 15, Núm. 3, pp. 275-280
-
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry
Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966
-
Prognostic role of tapse to pasp ratio in patients undergoing mitraclip procedure
Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-13
-
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
American Heart Journal, Vol. 237, pp. 104-115
-
Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score
Frontiers in Medicine, Vol. 8
2020
-
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry
Journal of Nephrology, Vol. 33, Núm. 4, pp. 737-745
-
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis
Frontiers in Endocrinology, Vol. 11
-
Transcatheter mitral repair for functional mitral regurgitation according to left ventricular function: A real-life propensity-score matched study
Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-14
2019
-
Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry
Journal of the American Heart Association, Vol. 8, Núm. 3
2018
-
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835
2016
-
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists
British Journal of Haematology, Vol. 174, Núm. 4, pp. 610-623